Pulse intravenous clomipramine for depressed adolescents: Double- blind, controlled trial

American Journal of Psychiatry

Volumn 154, Issue 5, 1997, Pages 668-673

  Sallee, Floyd R ^a   Vrindavanam, Nandagopal S ^b   Deas Nesmith, Deborah ^b   Carson, Stanley W ^b   Sethuraman, Gopalan ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIPRAMINE; SEROTONIN RECEPTOR;

ADOLESCENT; ARTICLE; BINDING SITE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROTRANSMISSION; PRIORITY JOURNAL; PULSATILE DRUG RELEASE; RANDOMIZED CONTROLLED TRIAL; SEROTONINERGIC SYSTEM;

EID: 0030900397     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.154.5.668     Document Type: Article

References (43)

1. Kashani JH, Carlson GA, Beck NC, Hoeper EW, Corcoran CM, McAllister JA, Fallahi C, Rosenberg TK, Reid JC: Depression, depressive symptoms, and depressed mood among a community sample of adolescents. Am J Psychiatry 1987; 144:931-934
2. Myers JK, Weissman MM, Tischler GL, Holzer CE, Leaf PJ, Orvaschel H, Anthony JC, Boyd JH, Burke J, Kramer M, Stoltzman R: Six-month prevalence of psychiatric disorders in three communities. Arch Gen Psychiatry 1984; 41:959-967
3. Brent DA, Perper JA, Goldstein CE, Kolko DJ, Allan MJ, Allman CJ, Zelenak JP: Risk factors for adolescent suicide. Arch Gen Psychiatry 1988; 41:581-588
4. Kramer E, Feiguine R: Clinical effects of amitriptyline in adolescent depression. J Am Acad Child Psychiatry 1983; 20:636-644
5. Ryan ND, Puig-Antich J, Cooper T, Rabinovich H, Ambrosini P, Davies M, King J, Torres D, Fried J: Imipramine in adolescent major depression: plasma level and clinical response. Acta Psychiatr Scand 1986; 73:275-288
6. Geller B, Cooper TB, Graham DL, Marsteller FA, Bryant DM: Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a "fixed plasma level" design. Psychopharmacol Bull 1990; 26:85-90
7. Ambrosini PJ, Bianchi MD, Rabinovich H, Elia J: Antidepressant treatments in children and adolescents, I: affective disorders. J Am Acad Child Adolesc Psychiatry 1993; 32:1-6
8. Ryan ND: The pharmacologic treatment of child and adolescent depression. Psychiatr Clin North Am 1992; 15:29-39
9. Maes M, Meltzer HY: The serotonin hypothesis of major depression, in Psychopharmacology: The Fourth Generation of Progress. Edited by Bloom FE, Kupfer DJ. New York, Raven Press, 1995, pp 933-944
10. Kutcher S, Malkin D, Silverberg J, Marton P, Williamson P, Malkin A, Szalai J, Katie M: Nocturnal cortisol, thyroid stimulating hormone, and growth hormone secretory profiles in depressed adolescents. J Am Acad Child Adolesc Psychiatry 1991; 30:407-414
11. DeVane CL, Sallee FR: Serotonin selective reuptake inhibitors in child and adolescent psychopharmacology: a review of published experience. J Clin Psychiatry 1996; 57:55-66
12. Brent DA, Ryan N, Dahl R, Birmaher B: Early-onset mood disorder, in Psychopharmacology: The Fourth Generation of Progress. Edited by Bloom FE, Kupfer DJ. New York, Raven Press, 1995, pp 1631-1642
13. Strober M, Lampert C, Schmidt S, Morrell W: The course of major depressive disorder in adolescents, I: recovery and risk of manic switching in a follow-up of psychotic and nonpsychotic subtypes. J Am Acad Child Adolesc Psychiatry 1993; 32: 34-42
14. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
15. Pollock BG, Perel JM, Nathan RS, Kupfer DJ: Acute antidepressant effect following pulse loading with intravenous and oral clomipramine. Arch Gen Psychiatry 1989; 46:29-35
16. Perel JM, Stiller RL, Pollock BG, Lin FC, Narayan S: Pharmaco-kinetic studies in oral and intravenous chlomipramine (abstract). Clin Chem 1986; 32:1059
17. Sallee FR, Pollack BG, Perel JM, Ryan ND, Stiller RL: Intravenous pulse loading of clomipramine in adolescents with depression. Psychopharmacol Bull 1989; 25:114-118
18. Chambers WJ, Puig-Antich J, Hirsch M, Paez P, Ambrosini PJ, Tabrizi MA, Davies M: The assessment of affective disorders in children and adolescents by semistructured interview. Arch Gen Psychiatry 1985; 42:696-702
19. Pollock BG, Perel JM, Shostak M, Antelman SM, Brandom B, Kupfer DJ: Understanding the response lag to tricyclics, I: application of pulse-loading regimens with intravenous clomipramine. Psychopharmacol Bull 1986; 22:214-219
20. Spitzer RL, Williams JBW, Gibbon M, First MB: Structured Clinical Interview for DSM-III-R - Patient Version 1.0 (SCID-P). Washington, DC, American Psychiatric Press, 1990
21. Hollingshead AB: Two-Factor Index of Social Position. New Haven, Yale University, 1957
22. Guy W (ed): ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76-338. Rockville, Md, US Department of Health, Education, and Welfare, 1976, pp 217-222
23. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961; 4:561-571
24. Lewinsohn PM, Clarke GN, Seeley JR, Rohde P: Major depression in community adolescents: age at onset, episode duration, and time to recurrence. J Am Acad Child Adolesc Psychiatry 1994; 33:809-818
25. Shain BN, King CA, Naylor M, Alessi N: Chronic depression and hospital course in adolescents. J Am Acad Child Adolesc Psychiatry 1991; 30:428-433
26. Koran LM, Faravelli C, Pallanti S: Intravenous clomipramine for obsessive-compulsive disorder. J Clin Psychopharmacol 1994; 14:216-218
27. Steingard RJ, DeMaso DR, Goldman SJ, Shorrock KL, Bucci JP: Current perspectives on the pharmacotherapy of depressive disorders in children and adolescents. Harvard Rev Psychiatry 1995; 2:313-326
28. Jensen PS, Ryan ND, Prien R: Psychopharmacology of child and adolescent major depression: present status and future directions. J Child and Adolescent Psychopharmacology 1992; 2:31-45
29. Boulos C, Kutcher S, Marton P, Simeon J, Ferguson B, Roberts N: Response to desipramine in adolescent major depression. Psychopharmacol Bull 1991; 27:59-65
30. Kye CH, Waterman GS, Ryan ND, Birmaher B, Williamson DE, Iyengar S, Dachille S: A randomized, controlled trial of amitriptyline in the acute treatment of adolescent major depression. J Am Acad Child Adolesc Psychiatry 1996; 35:1139-1144
31. Emslie GJ, Rush AJ, Weinberg WA, Kowatch RA, Hughes CW, Carmody T, Rintelmann J: A double-blind, randomized, placebo-controlled trial of of fluoxetine in depressed children and adolescents. Arch Gen Psychiatry (in press)
32. Simeon JD, Dinicola VF, Ferguson HB, Copping W: Adolescent depression: a placebo-controlled fluoxetine treatment study and follow-up. Prog Neuropsychopharmacol Biol Psychiatry 1990; 14:791-795
33. Boulos C, Kutcher S, Gardner D, Young E: An open naturalistic trial of fluoxetine in adolescents and young adults with treatment-resistant major depression. J Child and Adolescent Psychopharmacology 1992; 2:103-111
34. Apter A, Ratzoni G, King RA, Weizman A, Iancu I, Binder M, Riddle MA: Fluvoxamine open-label treatment of adolescent inpatient with obsessive compulsive disorder or depression. J Am Acad Child Adolesc Psychiatry 1994; 33:342-348
35. Jain DA, Birmaher B, Garcia M, Al-Shabbout M, Ryan N: Fluoxetine in children and adolescents with mood disorders: a chart review of efficacy and adverse effects. J Child and Adolescent Psychopharmacology 1992; 2:259-265
36. Sallee FR, Nesbitt L, Dougherty D, Hilal R, Nandagopal VS, Sethuraman G: Lymphocyte glucocorticoid receptor: predictor of sertraline response in adolescent major depressive disorder (MDD). Psychopharmacol Bull 1995; 31:339-345
37. Escobar JI, Flemenbaum A, Schiele BC: Chlorimipramine: a double-blind comparison of intravenous versus oral administration in depressed patients. Psychopharmacologia 1973; 33:111-116
38. Faravelli C, Broadhurst AD, Ambonetti A, Ballerini A, DeBlase L, LaMalfa G, Das M: Double-blind trial with oral versus intravenous chlorimipramine in primary depression. Biol Psychiatry 1983; 18:695-706
39. Warneke LB: Intravenous chlorimipramine in the treatment of obsessional disorder in adolescence: case report. J Clin Psychiatry 1985; 46:100-103
40. Strober M, Freeman R, Rigali J: The pharmacotherapy of depressive illness in adolescence. Psychopharmacol Bull 1990; 26:80-94
41. Ryan ND, Meyer V, Dachilie S, Mazzie D, Puig-Antich J: Lithium antidepressant augmentation in TCA-refractory depression in adolescents. J Am Acad Child Adolesc Psychiatry 1988; 27: 371-376
42. Modai I, Apter A, Meltzer M, Tyano S, Walevski A, Jerushalmy Z: Serotonin uptake by platelets of suicidal and aggressive adolescent psychiatric inpatients. Neuropsychobiology 1989; 21:9-13
43. Sallee FR, Nesmith D, Dougherty D, Sethuraman G: Pulse IV clomipramine in depressed adolescents (abstract). Clin Pharmacol Ther 1994; 55:137